Regulatory functions of the Mediator kinases CDK8 and CDK19

References

• Galbraith MD, Allen MA, Bensard CL, et al. HIF1A employs CDK8-Mediator to stimulate RNAPII elongation in response to hypoxia. Cell. 2013;153:1327–1339.
   PubMed Web of Science ®Google Scholar
• Kagey M, Newman J, Bilodeau S, et al. Mediator and Cohesin connect gene expression and chromatin architecture. Nature. 2010;467:430–435.
   PubMed Web of Science ®Google Scholar
• Phillips-Cremins JE, Sauria ME, Sanyal A, et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell. 2013;153:1281–1295.
   PubMed Web of Science ®Google Scholar
• Allen BL, Taatjes DJ. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol. 2015;16:155–166.
   PubMed Web of Science ®Google Scholar
• Davis MA, Larimore EA, Fissel BM, et al. The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator. Genes Dev. 2013;27:151–156.
   PubMed Web of Science ®Google Scholar
• Mo X, Kowenz-Leutz E, Xu H, et al. Ras induces mediator complex exchange on C/EBPb. Mol Cell. 2004;13:241–250.
   PubMed Web of Science ®Google Scholar
• Pavri R, Lewis B, Kim TK, et al. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell. 2005;18:83–96.
   PubMed Web of Science ®Google Scholar
• Taatjes DJ, Naar AM, Andel F, et al. Structure, function, and activator-induced conformations of the CRSP coactivator. Science. 2002;295:1058–1062.
   PubMed Web of Science ®Google Scholar
• Meyer KD, Donner AJ, Knuesel M, et al. Cooperative activity of CDK8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. Embo J. 2008;27:1447–1457.
   PubMed Web of Science ®Google Scholar
• Knuesel MT, Meyer KD, Bernecky C, et al. The human CDK8 subcomplex is a molecular switch that controls Mediator co-activator function. Genes Dev. 2009;23:439–451.
   PubMed Web of Science ®Google Scholar
• Tsai KL, Sato S, Tomomori-Sato C, et al. A conserved Mediator-CDK8 kinase module association regulates Mediator-RNA polymerase II interaction. Nat Struct Mol Biol. 2013;20:611–619.
   PubMed Web of Science ®Google Scholar
• Daniels DL, Ford M, Schwinn MK, et al. Mutual exclusivity of MED12/MED12L, MED13/13L, and CDK8/19 paralogs revealed within the CDK-Mediator kinase module. J Proteomics Bioinform. 2013;S2:004.
   Google Scholar
• Kapoor A, Goldberg MS, Cumberland LK, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010;468:1105–1109.
   PubMed Web of Science ®Google Scholar
• Firestein R, Bass AJ, Kim SY, et al. CDK8 is a colorectal cancer oncogene that regulates b-catenin activity. Nature. 2008;455:547–551.
   PubMed Web of Science ®Google Scholar
• Morris EJ, Ji J, Yang F, et al. E2F1 represses b-catenin transcription and is antagonized by both pRB and CDK8. Nature. 2008;455:552–556.
   PubMed Web of Science ®Google Scholar
• McCleland ML, Soukup TM, Liu SD, et al. Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis. J Pathol. 2015;237:508–519.
   PubMed Web of Science ®Google Scholar
• Donner AJ, Ebmeier CC, Taatjes DJ, et al. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol. 2010;17:194–201.
   PubMed Web of Science ®Google Scholar
• Adler AS, McCleland ML, Truong T, et al. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res. 2012;72:2129–2139.
   PubMed Web of Science ®Google Scholar
• Loncle N, Boube M, Joulia L, et al. Distinct roles for Mediator cdk8 module subunits in Drosophila development. Embo J. 2007;26:1045–1054.
   PubMed Web of Science ®Google Scholar
• Westerling T, Kuuluvainen E, Makela TP. Cdk8 is essential for preimplantation mouse development. Mol Cell Biol. 2007;27:6177–6182.
   PubMed Web of Science ®Google Scholar
• Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152:1237–1251.
   PubMed Web of Science ®Google Scholar
• Tapscott SJ, Davis RL, Thayer MJ, et al. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science. 1988;242:405–411.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101–106.
   PubMed Web of Science ®Google Scholar
• Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141–146.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920.
   PubMed Web of Science ®Google Scholar
• Heinz S, Romanoski CE, Benner C, et al. Effect of natural genetic variation on enhancer selection and function. Nature. 2013;503:487–492.
   PubMed Web of Science ®Google Scholar
• Lambert SA, Jolma A, Campitelli LF, et al. The human transcription factors. Cell. 2018;172:650–665.
   PubMed Web of Science ®Google Scholar
• Mullen AC, Orlando DA, Newman JJ, et al. Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell. 2011;147:565–576.
   PubMed Web of Science ®Google Scholar
• Neph S, Stergachis AB, Reynolds A, et al. Circuitry and dynamics of human transcription factor regulatory networks. Cell. 2012;150:1274–1286.
   PubMed Web of Science ®Google Scholar
• Trompouki E, Bowman TV, Lawton LN, et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell. 2011;147:577–589.
   PubMed Web of Science ®Google Scholar
• Deng W, Rupon JW, Krivega I, et al. Reactivation of developmentally silenced globin genes by forced chromatin looping. Cell. 2014;158:849–860.
   PubMed Web of Science ®Google Scholar
• Dowen JM, Fan ZP, Hnisz D, et al. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell. 2014;159:374–387.
   PubMed Web of Science ®Google Scholar
• Saint-Andre V, Federation AJ, Lin CY, et al. Models of human core transcriptional regulatory circuitries. Genome Res. 2016;26:385–396.
   PubMed Web of Science ®Google Scholar
• Novo CL, Javierre BM, Cairns J, et al. Long-range enhancer interactions are prevalent in mouse embryonic stem cells and are reorganized upon pluripotent state transition. Cell Rep. 2018;22:2615–2627.
   PubMed Web of Science ®Google Scholar
• Won H, de la Torre-Ubieta L, Stein JL, et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature. 2016;538:523–527.
   PubMed Web of Science ®Google Scholar
• Nord AS, Blow MJ, Attanasio C, et al. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell. 2013;155:1521–1531.
   PubMed Web of Science ®Google Scholar
• Franke M, Ibrahim DM, Andrey G, et al. Formation of new chromatin domains determines pathogenicity of genomic duplications. Nature. 2016;538:265–269.
   PubMed Web of Science ®Google Scholar
• Herz HM, Hu D, Shilatifard A. Enhancer malfunction in cancer. Mol Cell. 2014;53:859–866.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934–947.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–334.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307–319.
   PubMed Web of Science ®Google Scholar
• Pott S, Lieb JD. What are super-enhancers?. Nat Genet. 2015;47:8–12.
   PubMed Web of Science ®Google Scholar
• Bancerek J, Poss ZC, Steinparzer I, et al. CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity. 2013;38:250–262.
   PubMed Web of Science ®Google Scholar
• Nitulescu II, Meyer SC, Wen QJ, et al. Mediator kinase phosphorylation of STAT1 S727 promotes growth of neoplasms with JAK-STAT activation. EBioMedicine. 2017;26:112–125.
   PubMed Web of Science ®Google Scholar
• Aranda-Orgilles B, Saldana-Meyer R, Wang E, et al. MED12 regulates HSC-specific enhancers independently of mediator kinase activity to control hematopoiesis. Cell Stem Cell. 2016;19:784–799.
   PubMed Web of Science ®Google Scholar
• Pelish HE, Liau BB, Nitulescu II, et al. Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 2015;526:273–276.
   PubMed Web of Science ®Google Scholar
• Johannessen L, Sundberg TB, O’Connell DJ, et al. Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nat Chem Biol. 2017;13:1102–1108.
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455–461.
   PubMed Web of Science ®Google Scholar
• Chen H, Li C, Peng X, et al. Pan-cancer analysis of enhancer expression in nearly 9000 patient samples. Cell. 2018;173:386–399 e12.
   PubMed Web of Science ®Google Scholar
• Heinz S, Romanoski CE, Benner C, et al. The selection and function of cell type-specific enhancers. Nat Rev Mol Cell Biol. 2015;16:144–154.
   PubMed Web of Science ®Google Scholar
• Li G, Ruan X, Auerbach RK, et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell. 2012;148:84–98.
   PubMed Web of Science ®Google Scholar
• Dukler N, Booth GT, Huang YF, et al. Nascent RNA sequencing reveals a dynamic global transcriptional response at genes and enhancers to the natural medicinal compound celastrol. Genome Res. 2017;27:1816–1829.
   PubMed Web of Science ®Google Scholar
• Azofeifa JG, Allen MA, Hendrix JR, et al. Enhancer RNA profiling predicts transcription factor activity. Genome Res. 2018;28:334–344.
   Web of Science ®Google Scholar
• Arner E, Daub CO, Vitting-Seerup K, et al. Gene regulation. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347:1010–1014.
   PubMed Web of Science ®Google Scholar
• Franco HL, Nagari A, Malladi VS, et al. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis. Genome Res. 2018;28:159–170.
   PubMed Web of Science ®Google Scholar
• Kaikkonen MU, Spann NJ, Heinz S, et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell. 2013;51:310–325.
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Fei T, Chen Y, et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A. 2014;111:7319–7324.
   PubMed Web of Science ®Google Scholar
• Lyu X, Rowley MJ, Corces VG. Architectural proteins and pluripotency factors cooperate to orchestrate the transcriptional response of hESCs to temperature stress. Mol Cell. 2018;71:940–955.
   PubMed Web of Science ®Google Scholar
• Kuuluvainen E, Domenech-Moreno E, Niemela EH, et al. Depletion of Mediator kinase module subunits represses superenhancer-associated genes in colon cancer cells. Mol Cell Biol. 2018;38.
   PubMed Web of Science ®Google Scholar
• Poss ZC, Ebmeier CC, Odell AT, et al. Identification of Mediator kinase substrates in human cells using cortistatin A and quantitative phosphoproteomics. Cell Rep. 2016;15:436–450.
   PubMed Web of Science ®Google Scholar
• Sanyal A, Lajoie BR, Jain G, et al. The long-range interaction landscape of gene promoters. Nature. 2012;489:109–113.
   PubMed Web of Science ®Google Scholar
• Lai F, Orom UA, Cesaroni M, et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. 2013;494:497–501.
   PubMed Web of Science ®Google Scholar
• Plank JL, Dean A. Enhancer function: mechanistic and genome-wide insights come together. Mol Cell. 2014;55:5–14.
   PubMed Web of Science ®Google Scholar
• Schaukowitch K, Joo JY, Liu X, et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell. 2014;56:29–42.
   PubMed Web of Science ®Google Scholar
• Kulak NA, Pichler G, Paron I, et al. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods. 2014;11:319–324.
   PubMed Web of Science ®Google Scholar
• Iborra FJ, Pombo A, Jackson DA, et al. Active RNA polymerases are localized within discrete transcription “factories’ in human nuclei. J Cell Sci. 1996;109(Pt 6):1427–1436.
   PubMedGoogle Scholar
• Allahyar A, Vermeulen C, Bouwman BAM, et al. Enhancer hubs and loop collisions identified from single-allele topologies. Nat Genet. 2018;50:1151–1160.
   PubMed Web of Science ®Google Scholar
• Fukaya T, Lim B, Levine M. Enhancer control of transcriptional bursting. Cell. 2016;166:358–368.
   PubMed Web of Science ®Google Scholar
• Koehler MF, Bergeron P, Blackwood EM, et al. Development of a potent, specific CDK8 kinase inhibitor which phenocopies CDK8/19 knockout cells. ACS Med Chem Lett. 2016;7:223–228.
   PubMed Web of Science ®Google Scholar
• Audetat KA, Galbraith MD, Odell AT, et al. A kinase-independent role for cyclin-dependent kinase 19 in p53 response. Mol Cell Biol. 2017;37:e00626–16.
   PubMed Web of Science ®Google Scholar
• Chen M, Liang J, Ji H, et al. CDK8/19 Mediator kinases potentiate induction of transcription by NFkappaB. Proc Natl Acad Sci U S A. 2017;114:10208–10213.
   PubMed Web of Science ®Google Scholar
• Donner AJ, Szostek S, Hoover JM, et al. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell. 2007;27:121–133.
   PubMed Web of Science ®Google Scholar
• Levine M, Cattoglio C, Tjian R. Looping back to leap forward: transcription enters a new era. Cell. 2014;157:13–25.
   PubMed Web of Science ®Google Scholar
• Fanucchi S, Shibayama Y, Burd S, et al. Chromosomal contact permits transcription between coregulated genes. Cell. 2013;155:606–620.
   PubMed Web of Science ®Google Scholar
• Fullwood MJ, Liu MH, Pan YF, et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature. 2009;462:58–64.
   PubMed Web of Science ®Google Scholar
• Rawal Y, Chereji RV, Valabhoju V, et al. Gcn4 binding in coding regions can activate internal and canonical 5ʹ promoters in yeast. Mol Cell. 2018;70:297–311 e4.
   PubMed Web of Science ®Google Scholar
• Sigova AA, Mullen AC, Molinie B, et al. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A. 2013;110:2876–2881.
   PubMed Web of Science ®Google Scholar
• Reavey CT, Hickman MJ, Dobi KC, et al. Analysis of polygenic mutants suggests a role for mediator in regulating transcriptional activation distance in saccharomyces cerevisiae. Genetics. 2015;201:599–612.
   PubMed Web of Science ®Google Scholar
• Andrau J, van de Pasch L, Lijnzaad P, et al. Genome-wide location of the coactivator Mediator: binding without activation and transient cdk8 interaction on DNA. Mol Cell. 2006;22:179–192.
   PubMed Web of Science ®Google Scholar
• Jeronimo C, Langelier MF, Bataille AR, et al. Tail and kinase modules differently regulate core mediator recruitment and function in vivo. Mol Cell. 2016;64:455–466.
   PubMed Web of Science ®Google Scholar
• Petrenko N, Jin Y, Wong KH, et al. Mediator undergoes a compositional change during transcriptional activation. Mol Cell. 2016;64:443–454.
   PubMed Web of Science ®Google Scholar
• D’Urso A, Takahashi YH, Xiong B, et al. Set1/COMPASS and Mediator are repurposed to promote epigenetic transcriptional memory. Elife. 2016;5:e16691.
   Web of Science ®Google Scholar
• Dimitrova E, Kondo T, Feldmann A, et al. FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment. Elife. 2018;7.
   PubMed Web of Science ®Google Scholar
• Ostuni R, Piccolo V, Barozzi I, et al. Latent enhancers activated by stimulation in differentiated cells. Cell. 2013;152:157–171.
   PubMed Web of Science ®Google Scholar
• Law MJ, Finger MA. The Saccharomyces cerevisiae Cdk8 Mediator Represses AQY1 Transcription by Inhibiting Set1p-Dependent Histone Methylation. G3 (Bethesda). 2017;7:1001–1010.
   PubMedGoogle Scholar
• Agathocleous M, Harris WA. Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol. 2013;23:484–492.
   PubMed Web of Science ®Google Scholar
• Deberardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell. 2012;148:1132–1144.
   PubMed Web of Science ®Google Scholar
• Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2012;2:881–898.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Yang M, Soga T, Pollard PJ. Oncometabolites: linking altered metabolism with cancer. J Clin Invest. 2013;123:3652–3658.
   PubMed Web of Science ®Google Scholar
• Wang YH, Israelsen WJ, Lee D, et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell. 2014;158:1309–1323.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Kuchin S, Treich I, Carlson M. A regulatory shortcut between the Snf1 protein kinase and RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A. 2000;97:7916–7920.
   PubMed Web of Science ®Google Scholar
• Kuchin S, Yeghiayan P, Carlson M. Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. Proc Natl Acad Sci U S A. 1995;92:4006–4010.
   PubMed Web of Science ®Google Scholar
• Mousley CJ, Yuan P, Gaur NA, et al. A sterol-binding protein integrates endosomal lipid metabolism with TOR signaling and nitrogen sensing. Cell. 2012;148:702–715.
   PubMed Web of Science ®Google Scholar
• Song W, Treich I, Qian N, et al. SSN genes that affect transcriptional repression in Saccharomyces cerevisiae encode SIN4, ROX3, and SRB proteins associated with RNA polymerase II. Mol Cell Biol. 1996;16:115–120.
   PubMed Web of Science ®Google Scholar
• Zhao X, Feng D, Wang Q, et al. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest. 2012;122:2417–2427.
   PubMed Web of Science ®Google Scholar
• Lindsay AK, Morales DK, Liu Z, et al. Analysis of Candida albicans mutants defective in the Cdk8 module of mediator reveal links between metabolism and biofilm formation. PLoS Genet. 2014;10:e1004567.
   PubMed Web of Science ®Google Scholar
• Law MJ, Ciccaglione K. Fine-tuning of histone H3 Lys4 methylation during pseudohyphal differentiation by the CDK submodule of RNA polymerase II. Genetics. 2015;199:435–453.
   PubMed Web of Science ®Google Scholar
• Xie XJ, Hsu FN, Gao X, et al. CDK8-cyclin C Mediates nutritional regulation of developmental transitions through the ecdysone receptor in drosophila. PLoS Biol. 2015;13:e1002207.
   PubMed Web of Science ®Google Scholar
• Holstege FC, Jennings EG, Wyrick JJ, et al. Dissecting the regulatory circuitry of a eukaryotic genome. Cell. 1998;95:717–728.
   PubMed Web of Science ®Google Scholar
• Chi Y, Huddleston MJ, Zhang X, et al. Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev. 2001;15:1078–1092.
   PubMed Web of Science ®Google Scholar
• Hirst M, Kobor MS, Kuriakose N, et al. GAL4 is regulated by the RNA polymerase II holoenzyme-associated cyclin-dependent protein kinase SRB10/CDK8. Mol Cell. 1999;3:673–678.
   PubMed Web of Science ®Google Scholar
• Nelson C, Goto S, Lund K, et al. Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12. Nature. 2003;421:187–190.
   PubMed Web of Science ®Google Scholar
• Raithatha S, Su TC, Lourenco P, et al. Cdk8 regulates stability of the transcription factor Phd1 to control pseudohyphal differentiation of Saccharomyces cerevisiae. Mol Cell Biol. 2012;32:664–674.
   PubMed Web of Science ®Google Scholar
• Vincent O, Kuchin S, Hong SP, et al. Interaction of the srb10 kinase with sip4, a transcriptional activator of gluconeogenic genes in saccharomyces cerevisiae. Mol Cell Biol. 2001;21:5790–5796.
   PubMed Web of Science ®Google Scholar
• Galbraith MD, Andrysik Z, Pandey A, et al. CDK8 Kinase Activity Promotes Glycolysis. Cell Rep. 2017;21:1495–1506.
   PubMed Web of Science ®Google Scholar
• Feng D, Youn DY, Zhao X, et al. mTORC1 down-regulates cyclin-dependent kinase 8 (CDK8) and cyclin C (CycC). PLoS One. 2015;10:e0126240.
   PubMed Web of Science ®Google Scholar
• Amoasii L, Holland W, Sanchez-Ortiz E, et al. A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism. Genes Dev. 2016;30:434–446.
   PubMed Web of Science ®Google Scholar
• Grueter CE, van Rooij E, Johnson BA, et al. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell. 2012;149:671–683.
   PubMed Web of Science ®Google Scholar
• Baskin KK, Grueter CE, Kusminski CM, et al. MED13-dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver. EMBO Mol Med. 2014;6:1610–1621.
   PubMed Web of Science ®Google Scholar
• Lee JH, Bassel-Duby R, Olson EN. Heart- and muscle-derived signaling system dependent on MED13 and Wingless controls obesity in Drosophila. Proc Natl Acad Sci U S A. 2014;111:9491–9496.
   PubMed Web of Science ®Google Scholar
• Cee VJ, Chen DYK, Lee MR, et al. Cortistatin A is a high-affinity ligand of protein kinases ROCK, CDK8, and CDK11. Angew Chem Int Ed. 2009;48:8952–8957.
   PubMed Web of Science ®Google Scholar
• Fabian MA, Biggs WH 3rd, Treiber DK, et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol. 2005;23:329–336.
   PubMed Web of Science ®Google Scholar
• Knuesel MT, Meyer KD, Donner AJ, et al. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of Mediator. Mol Cell Biol. 2009;29:650–661.
   PubMed Web of Science ®Google Scholar
• Hatcher JM, Wang ES, Johannessen L, et al. Development of highly potent and selective steroidal inhibitors and degraders of CDK8. ACS Med Chem Lett. 2018;9:540–545.
   PubMed Web of Science ®Google Scholar
• Ito T, Ando H, Suzuki T, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327:1345–1350.
   PubMed Web of Science ®Google Scholar
• Lai AC, Crews CM. Induced protein degradation: an emerging drug discovery paradigm. Nat Rev Drug Discov. 2017;16:101–114.
   PubMed Web of Science ®Google Scholar
• Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol. 2015;50:393–426.
   PubMed Web of Science ®Google Scholar
• Shaffer SM, Dunagin MC, Torborg SR, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431–435.
   PubMed Web of Science ®Google Scholar
• Huang S, Holzel M, Knijnenburg T, et al. MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling. Cell. 2012;151:937–950.
   PubMed Web of Science ®Google Scholar
• Luo XL, Deng CC, Su XD, et al. Loss of MED12 induces tumor dormancy in human epithelial ovarian cancer via downregulation of EGFR. Cancer Res. 2018;78:3532–3543.
   PubMed Web of Science ®Google Scholar
• Park MJ, Shen H, Spaeth JM, et al. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem. 2018;293:4870–4882.
   PubMed Web of Science ®Google Scholar
• Rusan M, Li K, Li Y, et al. Suppression of adaptive responses to targeted cancer therapy by transcriptional repression. Cancer Discov. 2018;8:59–73.
   PubMed Web of Science ®Google Scholar
• Kanin EI, Kipp RT, Kung C, et al. Chemical inhibition of the TFIIH-associated kinase cdk7/kin28 does not impair global mRNA synthesis. Proc Natl Acad Sci U S A. 2007;104:5812–5817.
   PubMed Web of Science ®Google Scholar
• Bu P, Evrard YA, Lozano G, et al. Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol Cell Biol. 2007;27:3405–3416.
   PubMed Web of Science ®Google Scholar
• Illingworth RS, Moffat M, Mann AR, et al. The E3 ubiquitin ligase activity of RING1B is not essential for early mouse development. Genes Dev. 2015;29:1897–1902.
   PubMed Web of Science ®Google Scholar
• Li N, Fassl A, Chick J, et al. Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol. 2014;16:1080–1091.
   PubMed Web of Science ®Google Scholar
• Karwacki-Neisius V, Goke J, Osorno R, et al. Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell. 2013;12:531–545.
   PubMed Web of Science ®Google Scholar
• Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379–391.
   PubMed Web of Science ®Google Scholar
• Mayer A, Lidschreiber M, Siebert M, et al. Uniform transitions of the general RNA polymerase II transcription complex. Nat Struct Mol Biol. 2010;17:1272–1278.
   PubMed Web of Science ®Google Scholar
• Rhee HS, Pugh BF. Genome-wide structure and organization of eukaryotic pre-initiation complexes. Nature. 2012;483:295–301.
   PubMed Web of Science ®Google Scholar
• Turunen M, Spaeth JM, Keskitalo S, et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep. 2014;7:654–660.
   PubMed Web of Science ®Google Scholar
• Elmlund H, Baraznenok V, Lindahl M, et al. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc Natl Acad Sci U S A. 2006;103:15788–15793.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Shrinivas K, Young RA, et al. A phase separation model for transcriptional control. Cell. 2017;169:13–23.
   PubMed Web of Science ®Google Scholar
• Bergeron-Sandoval LP, Safaee N, Michnick SW. Mechanisms and Consequences of Macromolecular Phase Separation. Cell. 2016;165:1067–1079.
   PubMed Web of Science ®Google Scholar
• Toth-Petroczy A, Oldfield CJ, Simon I, et al. Malleable machines in transcription regulation: the mediator complex. PLoS Comput Biol. 2008;4:e1000243.
   PubMed Web of Science ®Google Scholar
• Wang J, Choi JM, Holehouse AS, et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell. 2018;174:688–699 e16.
   PubMed Web of Science ®Google Scholar
• Cho WK, Spille JH, Hecht M, et al. Mediator and RNA polymerase II clusters associate in transcription-dependent condensates. Science. 2018;361:412–415.
   PubMed Web of Science ®Google Scholar
• Sabari BR, Dall’Agnese A, Boija A, et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science. 2018;361:eear3958.
   Web of Science ®Google Scholar
• Kwon I, Kato M, Xiang S, et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155:1049–1060.
   PubMed Web of Science ®Google Scholar
• Boehning M, Dugast-Darzacq C, Rankovic M, et al. RNA polymerase II clustering through carboxy-terminal domain phase separation. Nat Struct Mol Biol. 2018;25:833–840.
   PubMed Web of Science ®Google Scholar
• Chong S, Dugast-Darzacq C, Liu Z, et al. Imaging dynamic and selective low-complexity domain interactions that control gene transcription. Science. 2018;361:eaar2555.
   PubMed Web of Science ®Google Scholar
• Ebmeier CC, Taatjes DJ. Activator-Mediator binding regulates Mediator-cofactor interactions. Proc Natl Acad Sci U S A. 2010;107:11283–11288.
   PubMed Web of Science ®Google Scholar
• Naar AM, Taatjes DJ, Zhai W, et al. Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation. Genes Dev. 2002;16:1339–1344.
   PubMed Web of Science ®Google Scholar
• Tantale K, Mueller F, Kozulic-Pirher A, et al. A single-molecule view of transcription reveals convoys of RNA polymerases and multi-scale bursting. Nat Commun. 2016;7:12248.
   PubMed Web of Science ®Google Scholar
• Lee K, Hsiung CC, Huang P, et al. Dynamic enhancer-gene body contacts during transcription elongation. Genes Dev. 2015;29:1992–1997.
   PubMed Web of Science ®Google Scholar
• Dale T, Clarke PA, Esdar C, et al. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol. 2015;11:973–980.
   PubMed Web of Science ®Google Scholar
• Clarke PA, Ortiz-Ruiz MJ, TePoele R, et al. Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases. Elife. 2016;5:e20722.
   PubMed Web of Science ®Google Scholar
• Dosztanyi Z. Prediction of protein disorder based on IUPred. Protein Sci. 2018;27:331–340.
   PubMed Web of Science ®Google Scholar
• Mallinger A, Schiemann K, Rink C, et al. Discovery of potent, selective, and orally bioavailable small-molecule modulators of the Mediator complex-associated kinases CDK8 and CDK19. J Med Chem. 2016;59:1078–1101.
   PubMed Web of Science ®Google Scholar
• Schiemann K, Mallinger A, Wienke D, et al. Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore. Bioorg Med Chem Lett. 2016;26:1443–1451.
   PubMed Web of Science ®Google Scholar
• Bergeron P, Koehler MF, Blackwood EM, et al. Design and development of a series of potent and selective type II inhibitors of CDK8. ACS Med Chem Lett. 2016;7:595–600.
   PubMed Web of Science ®Google Scholar
• Czodrowski P, Mallinger A, Wienke D, et al. Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening. J Med Chem. 2016;59:9337–9349.
   PubMed Web of Science ®Google Scholar
• Mallinger A, Schiemann K, Rink C, et al. 2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with potent, selective affinity for CDK8/19. ACS Med Chem Lett. 2016;7:573–578.
   PubMed Web of Science ®Google Scholar
• Rzymski T, Mikula M, Zylkiewicz E, et al. SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. Oncotarget. 2017;8:33779–33795.
   PubMedGoogle Scholar
• Porter DC, Farmaki E, Altilia S, et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012;109:13799–13804.
   PubMed Web of Science ®Google Scholar
• Schneider EV, Bottcher J, Blaesse M, et al. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder. J Mol Biol. 2011;412:251–266.
   PubMed Web of Science ®Google Scholar